NCM
TCBPW

Nantahala Capital Management’s TC BioPharm (Holdings) plc Warrants TCBPW Stock Holding History

Nantahala Capital Management’s Portfolio TCBPW Stock Details TCBPW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-235,294
Closed -$2.33K – 160
2024
Q4 		$2.33K Hold
235,294
– – ﹤0.01% 136
2024
Q3 		$4.28K Hold
235,294
– – ﹤0.01% 139
2024
Q2 		$2.94K Hold
235,294
– – ﹤0.01% 130
2024
Q1 		$4.71K Hold
235,294
– – ﹤0.01% 122
2023
Q4 		$7.65K Hold
235,294
– – ﹤0.01% 127
2023
Q3 		$5.18K Hold
235,294
– – ﹤0.01% 133
2023
Q2 		$10.1K Hold
235,294
– – ﹤0.01% 123
2023
Q1 		$23.5K Hold
235,294
– – ﹤0.01% 123
2022
Q4 		$21K Hold
235,294
– – ﹤0.01% 115
2022
Q3 		$29K Hold
235,294
– – ﹤0.01% 114
2022
Q2 		$56K Hold
235,294
– – ﹤0.01% 116
2022
Q1 		$117K Buy
+235,294
New +$109K 0.01% 116

Nantahala Capital Management's TCBPW Position: Q1 2025 in Review

Nantahala Capital Management sold out of TC BioPharm (Holdings) plc Warrants (TCBPW) in Q1 2025, closing a stake of 235,294 shares — an estimated $2.33K sold.

Nantahala Capital Management first reported a position in TCBPW in Q1 2022 and held it in 12 quarters. The position peaked at $117K in Q1 2022. 0 funds tracked by Wall St. Rank hold TCBPW as of Q1 2025.

  • Nantahala Capital Management reported no remaining TC BioPharm (Holdings) plc Warrants position as of Q1 2025 after selling out during the quarter.
  • Nantahala Capital Management sold 235,294 TC BioPharm (Holdings) plc Warrants shares in Q1 2025, an estimated $2.33K.
  • Nantahala Capital Management first reported a position in TC BioPharm (Holdings) plc Warrants in Q1 2022 and held it in 12 quarters.
  • Nantahala Capital Management's TC BioPharm (Holdings) plc Warrants position peaked at $117K in Q1 2022.
  • 0 funds tracked by Wall St. Rank held TC BioPharm (Holdings) plc Warrants as of Q1 2025.

Based on Nantahala Capital Management's 13F filing for Q1 2025, filed 15 May 2025.